A PROSPECTIVE, RANDOMIZED, PHASE III TRIAL OF FLAC (5-FLUOROURACIL, LEUCOVORIN, ADRIAMYCIN, CYTOXAN) CHEMOTHERAPY WITH GM-CSF (GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR) VERSUS PIXY 321 IN ADVANCED BREAST CANCER: